🔎 Trials Near Me

Dachaigh › Obesity › North Carolina › Charlotte

Sgrùdaidhean clionaigeach Obesity ann an Charlotte, NC

Tha 16 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann agus timcheall air Charlotte (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

A’ fastadhÌre 3
  • Novant Health Heart and Vascular Institute, Charlotte
  • Monroe Biomedical Research, Monroe · 24 mìle air falbh
Aoisean 45 gu 99 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

A’ fastadhÌre 2
  • Monroe Biomedical Research /ID# 282009, Monroe · 24 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07752979

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

A’ fastadhÌre 2
  • Monroe Biomedical Research, Monroe · 24 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

A’ fastadhÌre 3
  • Monroe Biomedical Research, Monroe · 24 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

A’ fastadhÌre 3
  • Research Site, Monroe · 24 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

A’ fastadhÌre 3
  • AURORA-2 Clinical Site, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

A’ fastadhÌre 3
  • AURORA-1 Clinical Site, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743463

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
  • ACCOMPLISH-2 Research Site, Charlotte
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

A’ fastadhÌre 2
  • Monroe Biomedical Research, Monroe · 24 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

A’ fastadhÌre 4
  • Onsite Clinical Solutions - Huntersville, Huntersville · 13 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

A’ fastadhÌre 3
  • Kailera Clinical Site, Monroe · 24 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284901

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

A’ fastadhÌre 2
  • Levine Children's Hospital, Charlotte
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

A’ fastadhÌre 3
  • Piedmont Research Partners, LLC, Fort Mill · 16 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

A’ fastadhÌre 3
  • ACCOMPLISH-1 Research Site, Charlotte
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

A’ fastadhÌre 1
  • Monroe Biomedical Research, LLC, Monroe · 24 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

A’ fastadhÌre 2
  • Monroe Biomedical Research, Monroe · 24 mìle air falbh
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07570758

Sgrùdaidhean Obesity ann am bailtean eile

Sgrùdaidhean eile ann an Charlotte

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.